BioSmart Brief: Highlights NeoStem's PreSERVE Trial $NBS
Friday, April 13, 2012 at 10:48AM
DDE Editor in Regenerative Medicine, nbs

PreSERVE-AMI tests autologous stem cell treatment for heart attack
Doctors at Orlando Health have started a trial as part of the nationwide PreSERVE-AMI study of pelvic bone marrow stem cells in treating tissue damage after a heart attack. The study of autologous transplant will involve 160 patients at 34 sites. American City Business Journals/Orlando, Fla.

Article originally appeared on Daily Dose Equities - Wall Street Analysis for Biomedical Research (http://dailydoseequities.filmannex.com/).
See website for complete article licensing information.